Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binghe Xu

Showing results (21-30 of 406) with videos related to

Pageof 41
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 27, 2024
Spotlight on ideal target antigens and resistance in antibody-drug conjugates: Strategies for competitive advancementMingxia Jiang, Qiao Li, Binghe Xu
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 15, 2015
[Polymorphisms of microRNA genes and their association with breast cancer risk]Ping Zhang, Fei Ma, Binghe Xu
Cancer Innovation|February 21, 2025
Artificial Intelligence and Breast Cancer Management: From Data to the ClinicKaixiang Feng, Zongbi Yi, Binghe Xu
Medicinal Research Reviews|June 26, 2024
Poly (adenosine diphosphate-ribose) polymerase inhibitors in the treatment of triple-negative breast cancer with homologous repair deficiencyPeng Yuan, Nan Ma, Binghe Xu
Cancer Letters|February 21, 2025
The biological and technical challenges facing utilizing circulating tumor DNA in non-metastatic breast cancer patientsZihang Zeng, Zongbi Yi, Binghe Xu
Cancer Innovation|December 13, 2023
Pooled analyses of randomized controlled trials on pyrotinib plus capecitabine and a rethink of the first-line options for HER2-positive relapsed or metastatic breast cancerXiuwen Guan, Fei Ma, Binghe Xu
Cancer Chemotherapy and Pharmacology|May 22, 2010
Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatmentJiayu Wang, Ying Fan, Binghe Xu
Frontiers in Oncology|July 18, 2022
A Novel Prognostic Nomogram for Predicting Survival of Hormone Receptor-Positive and HER2 Negative Advanced Breast Cancer Among the Han-PopulationYimin Zhu, Jiayu Wang, Binghe Xu
Journal of Personalized Medicine|March 29, 2023
Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast CancerYiqun Han, Jiayu Wang, Binghe Xu
Journal of Cancer Research and Therapeutics|March 8, 2024
Fragmentation patterns of cell-free DNA and somatic mutations in the urine of metastatic breast cancer patientsShaoyan Lin, Shusen Wang, Binghe Xu
Pageof 41

Showing results (21-30 of 406) with videos related to

Sort By:
Pageof 41
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 27, 2024
Spotlight on ideal target antigens and resistance in antibody-drug conjugates: Strategies for competitive advancementMingxia Jiang, Qiao Li, Binghe Xu
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 15, 2015
[Polymorphisms of microRNA genes and their association with breast cancer risk]Ping Zhang, Fei Ma, Binghe Xu
Cancer Innovation|February 21, 2025
Artificial Intelligence and Breast Cancer Management: From Data to the ClinicKaixiang Feng, Zongbi Yi, Binghe Xu
Medicinal Research Reviews|June 26, 2024
Poly (adenosine diphosphate-ribose) polymerase inhibitors in the treatment of triple-negative breast cancer with homologous repair deficiencyPeng Yuan, Nan Ma, Binghe Xu
Cancer Letters|February 21, 2025
The biological and technical challenges facing utilizing circulating tumor DNA in non-metastatic breast cancer patientsZihang Zeng, Zongbi Yi, Binghe Xu
Cancer Innovation|December 13, 2023
Pooled analyses of randomized controlled trials on pyrotinib plus capecitabine and a rethink of the first-line options for HER2-positive relapsed or metastatic breast cancerXiuwen Guan, Fei Ma, Binghe Xu
Cancer Chemotherapy and Pharmacology|May 22, 2010
Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatmentJiayu Wang, Ying Fan, Binghe Xu
Frontiers in Oncology|July 18, 2022
A Novel Prognostic Nomogram for Predicting Survival of Hormone Receptor-Positive and HER2 Negative Advanced Breast Cancer Among the Han-PopulationYimin Zhu, Jiayu Wang, Binghe Xu
Journal of Personalized Medicine|March 29, 2023
Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast CancerYiqun Han, Jiayu Wang, Binghe Xu
Journal of Cancer Research and Therapeutics|March 8, 2024
Fragmentation patterns of cell-free DNA and somatic mutations in the urine of metastatic breast cancer patientsShaoyan Lin, Shusen Wang, Binghe Xu
Pageof 41